摘要
目的评价30例伊曲康唑治疗肺部真菌感染的临床疗效与安全性。方法将61例肺部真菌感染患者随机分成研究组30例和对照验组31例,对照组给予氟康唑治疗,研究组给予伊曲康唑治疗,对临床资料及治疗结果进行回顾分析。结果经过治疗,研究组总有效率73.3%,对照组总有效率51.6%,两组比较差异有统计学意义(P<0.05)。结论伊曲康唑注射液治疗肺部真菌感染安全、有效。
Objective To study the clinical effect and safety of Itraconazole for the treatment of pulmonary fungal infection.Methods Totally 61cases of pulmonary infection patients were randomly divided into the treatment group 30 cases and the control group 31 cases.The control group was given Fluconazol,The treatment group was given Itraconazole.Then the clinical data and the treatment course were retrospectively analyzed.Results After treatment,the treatment group total effective rate was 73.3%,the control group,total effective rate was 51.6%.The difference was statisticully significant（P〈0.05）.Conclusions Itraconazole treating pulmonary fungal infection was safe and effective
出处
《医药论坛杂志》
2011年第9期81-82,共2页
Journal of Medical Forum
关键词
伊曲康唑
肺部
真菌感染
Itraconazole
Pulmonary
Fungal infection
